Fund HoldingsAtlas Venture Life Science Advisors, LLC

Total Portfolio Value
$819.65M
Total Bought
$0
Total Sold
$150.09M
Net Transaction
-$150.09M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
Disc Medicine, Inc.(IRON)2,509,4562,509,4560123,315159,10019.41%+35,785
Korro Bio, Inc.1,137,1491,137,149038,00443,2915.28%+5,288
Aerovate Therapeutics, Inc.1,799,2321,799,23203,7604,7680.58%+1,008
Spero Therapeutics, Inc.402,885305,255-97,6305403140.04%-225
Ikena Oncology, Inc.5,018,1785,018,17808,6818,2301.00%-452
Dianthus Therapeutics, Inc.(DNTH)76,9790-76,9792,1080-2,108
Tectonic Therapeutics, Inc.378,44778,447-300,00011,4673,6220.44%-7,845
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,257089,57381,4719.94%-8,102
Vigil Neuroscience, Inc.5,836,8745,836,874019,8459,9231.21%-9,923
Generation Bio, Co.8,279,4848,279,484020,4508,7761.07%-11,674
Kymera Therapeutics, Inc.(KYMR)4,896,4624,896,4620231,750196,98524.03%-34,765
Third Harmonic Bio, Inc.10,907,85910,402,286-505,573147,801107,04013.06%-40,762
Q32 Bio, Inc.2,092,1062,092,106093,3507,1970.88%-86,153
Dyne Therapeutics, Inc.(DYN)8,020,1368,019,354-782288,083188,93623.05%-99,147
Page 1 of 1